ethyl protocatechuate has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Li, W; Sun, Y; Xu, Y; Zhao, X; Zhou, L | 1 |
| Hou, G; Li, W; Liu, S; Lou, X; Xu, Y; Zhao, X; Zhou, D | 1 |
2 other study(ies) available for ethyl protocatechuate and Esophageal Neoplasms
| Article | Year |
|---|---|
A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Hydroxybenzoates; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mitochondrial Membranes; Prolyl-Hydroxylase Inhibitors; Proto-Oncogene Proteins; RNA Interference; RNA, Small Interfering; S Phase Cell Cycle Checkpoints | 2014 |
The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.
Topics: 20-Hydroxysteroid Dehydrogenases; Apoptosis; Autophagy; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Hydroxybenzoates; Hydroxysteroid Dehydrogenases; RNA Interference | 2016 |